TechConnect Innovation Program

Timed release of brain energy molecules for chronotherapy, memory preservation

Able Cerebral, LLC, PA, United States

TECHNOLOGY SUMMARY

matrix formulation, delayed release coating, dual phase controlled release technology, chronotherapy, Somogyi effect prevention, mild cognitive impairment (MCI) and Alzheimer’s disease (AD) progression prevention and memory preservation; different stage patent applications filed for advanced therapy systems.

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Ready to Market

Technology Readiness Level: TRL 9

FIGURES OF MERIT

Value Proposition: 1). our first product is ready for world-wide diabetics population; it is much superior to any food products
2). our innovative technologies for Alzheimer's and cognitive impairment patients is targeting the root cause of the illness; there is no comparable product on market.

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

Showcase Booth #: 52T

Website: www.AbleCerebral.com, www.4AmGlucose.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: registered, in process of applying US government grants, such as NIH and SBIR

Primary Sources of Funding: Angel, Friends, Family

Looking for: Both Funding and Development Partners